Elicera Therapeutics

Elicera Therapeutics is a clinical-stage immuno-oncology company that develops cell and gene therapies for immune-based cancer treatments. Its products include iTANK, a technology platform used to immune enhancement of treatments; ELC-301, a CAR T-cell therapy to treat B-cell lymphoma, etc.